Search

Animation about human papillomavirus (HPV) vaccines.

Is mRNA technology something completely new? How does it work and how is it used in developing vaccines for infectious diseases?

How was it possible to develop COVID-19 vaccines so quickly? Watch our animation to learn more about their production.

Statement by ECDC Director, Dr Andrea Ammon, on the fourth dose of the mRNA COVID-19 vaccine.

John Kinsman, expert on behaviour change, explains the key points of ECDC's report on facilitating COVID-19 vaccination acceptance and uptake in the EU/EEA, published on 15 October 2021.

Statement from Director Dr. Andrea Ammon as ECDC publishes a threat assessment brief on the implications of the spread of the Delta variant of concern for the EU/EEA.

It's not known when potential COVID-19 #vaccines will be available for use in the EU/EEA and the UK, but supply is likely to be limited in the early stages. Countries will therefore need to develop a vaccination strategy and identify priority groups for #vaccination.

Tetanus is transmitted by bacteria living in soil, animal saliva and manure which can enter the body through minor wounds on the skin. Today, a widely used vaccine protects against tetanus.

Effective worldwide vaccination campaigns have dramatically reduced the number of deadly infections. Watch our video (turn on subtitles in your language!) and learn more about the vaccination success stories on the fight with smallpox, polio, tetanus and measles.

Vaccines have been used to prevent diseases in millions of people worldwide. But who monitors the safety of vaccines and how do they do it?